<h2 id="mechanism-of-action-">Mechanism of Action <sup id="fnref:1" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup></h2>
<ul>
  <li>Aprepitant is a  neurokinin-1 (NK1) receptor antagonist. NK receptors in the brain are involved in nausea.</li>
</ul>
<h2 id="pharmacology-">Pharmacology <sup id="fnref:1:1" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup></h2>
<ul>
  <li><strong>Half-life:</strong> Approximately 40 hours
    <h2 id="indications-">Indications <sup id="fnref:1:2" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup></h2>
  </li>
  <li>Very effective in reducing the incidence of [[Post-operative Nausea and Vomiting]]
    <h2 id="dosage-">Dosage <sup id="fnref:1:3" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup></h2>
  </li>
  <li>40 mg or 80 mg (only 80 mg formulation is available in Calgary)</li>
</ul>
<h2 id="complications-">Complications <sup id="fnref:2" role="doc-noteref"><a href="#fn:2" class="footnote" rel="footnote">2</a></sup></h2>
<ul>
  <li>In patients receiving hormonal contraceptive therapy, alternative contraception should be used for 1 month following administration.</li>
  <li>
    <h2 id="references">References</h2>
  </li>
</ul>
<div class="footnotes" role="doc-endnotes">
  <ol>
    <li id="fn:1" role="doc-endnote">
      <p>Tong J. Gan, Kumar G. Belani, Sergio Bergese, Frances Chung, Pierre Diemunsch, Ashraf S. Habib, Zhaosheng Jin, Anthony L. Kovac, Tricia A. Meyer, Richard D. Urman, Christian C. Apfel, Sabry Ayad, Linda Beagley, Keith Candiotti, Marina Englesakis, Traci L. Hedrick, Peter Kranke, Samuel Lee, Daniel Lipman, Harold S. Minkowitz, John Morton, Beverly K. Philip. Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting, 2020. <a href="#fnref:1" class="reversefootnote" role="doc-backlink">&#8617;</a> <a href="#fnref:1:1" class="reversefootnote" role="doc-backlink">&#8617;<sup>2</sup></a> <a href="#fnref:1:2" class="reversefootnote" role="doc-backlink">&#8617;<sup>3</sup></a> <a href="#fnref:1:3" class="reversefootnote" role="doc-backlink">&#8617;<sup>4</sup></a></p>
    </li>
    <li id="fn:2" role="doc-endnote">
      <p>https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021549s015lbl.pdf <a href="#fnref:2" class="reversefootnote" role="doc-backlink">&#8617;</a></p>
    </li>
  </ol>
</div>